Literature DB >> 16084603

INGAP-related pentadecapeptide: its modulatory effect upon insulin secretion.

María I Borelli1, Luiz F Stoppiglia, Luiz F Rezende, Luis E Flores, Héctor Del Zotto, Antonio C Boschero, Juan J Gagliardino.   

Abstract

We examined the effects of a pentadecapeptide having the 104-118 aminoacid sequence of islet neogenesis-associated protein (INGAP-PP) on insulin secretion, and the morphological characteristics of adult and neonatal pancreatic rat islets cultured in RPMI and 10 mM glucose for 4 days, with or without different INGAP-PP concentrations (0.1-100 mug/ml). A scrambled 15 aminoacid peptide was used as control for the specificity of INGAP-PP effect. Cultured neonatal and adult islets released insulin in response to glucose (2.8-16.7 mM) in a dose-dependent manner, and to leucine and arginine (10 mM). In all cases, the response was greater in adult islets. INGAP-PP added to the culture medium significantly enhanced glucose- and aminoacid-induced insulin release in both adult and newborn rats; however, no changes were observed with the scrambled peptide. Similar results were obtained incubating freshly isolated adult rat islets with INGAP-PP. Whereas INGAP-PP did not induce significant changes in islet survival rate or proportion/number of islet cells, it increased significantly beta-cell size. This first demonstration of the enhancing effect of INGAP-PP on the beta-cell secretory response of adult and newborn islets opens a new avenue to study its production mechanism and potential use to increase the secretory capacity of endogenous islets in intact animals or of islets preserved for future transplants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084603     DOI: 10.1016/j.regpep.2005.07.003

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

Review 1.  A role for islet neogenesis in curing diabetes.

Authors:  G L Pittenger; D Taylor-Fishwick; A I Vinik
Journal:  Diabetologia       Date:  2009-03-07       Impact factor: 10.122

2.  Mechanisms of action of islet neogenesis-associated protein: comparison of the full-length recombinant protein and a bioactive peptide.

Authors:  Maria Petropavlovskaia; Jamal Daoud; Jonathan Zhu; Mandana Moosavi; Jieping Ding; Julia Makhlin; Beatrice Assouline-Thomas; Lawrence Rosenberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-31       Impact factor: 4.310

3.  Evidence for the homeostatic regulation of induced beta cell mass expansion.

Authors:  M A Lipsett; E B Austin; M L Castellarin; J Lemay; L Rosenberg
Journal:  Diabetologia       Date:  2006-10-03       Impact factor: 10.122

4.  Pancreatic islet immunoreactivity to the Reg protein INGAP.

Authors:  David A Taylor-Fishwick; Angela Bowman; Maricarmen Korngiebel-Rosique; Aaron I Vinik
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

5.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

6.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

7.  Regenerating proteins and their expression, regulation and signaling.

Authors:  Abhirath Parikh; Anne-Fleur Stephan; Emmanuel S Tzanakakis
Journal:  Biomol Concepts       Date:  2011-11-10

Review 8.  Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges.

Authors:  Zijing Chen; Shawna Downing; Emmanuel S Tzanakakis
Journal:  Front Cell Dev Biol       Date:  2019-10-22

9.  Islet neogenesis associated protein (INGAP) protects pancreatic β cells from IL-1β and IFNγ-induced apoptosis.

Authors:  Eni Nano; Maria Petropavlovskaia; Lawrence Rosenberg
Journal:  Cell Death Discov       Date:  2021-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.